Confirmed Speakers
Irina Alafuzoff, Sweden: Tau pathology (incidence and distribution) in humans in various ages and clinical conditions
Johannes Attems, UK: The role of tau in the multi-morbid old brain
Jesus Avila, Spain: Influence of tau levels and phosphorylation in cognition
Dirk Beher, Switzerland: O-GlcNAcase inhibitors for tauopathies – translation of a research finding to a clinical candidate molecule
David Blum, France: Tau: a new regulator of brain insulin signaling
Jean-Pierre Brion, Belgium: Tau pathology propagation in in vivo models induced by native human Alzheimer PHF
Morvane Colin, France: Tau intercellular transfer: from TNTs to extracellular vesicles
Thibaud Lebouvier, Vincent Deramecourt, Florence Pasquier, France: Clinical and neuropathological aspects of Tauopathies
Bart Dermaut, Gand, Belgium/Rijsel, France A developmental role for Tau in adult-onset neurodegenerative disease?
Marie Galas, France: Nuclear Tau regulates the structure of neuronal pericentromeric heterochromatin
Johan Gobom and Kina Höglund (Henrik Zetterberg lab), Sweden: Overview of tau biomarkers in CSF and blood
Michel Goedert, UK: The atomic structures of Tau filaments from Alzheimer's disease brain
Malika Hamdane, France: Amino-truncated Tau species
Günter Höglinger, Germany: PSP and CBD: human tauopathy model diseases.
Illana Gozes, Israel: ADNP: indirect interactions with tau determine cellular faith
Diane Hanger, UK: Tauopathy and cognitive dysfunction induced by minimal expression of a disease-related fragment of wild-type human tau in Tau35 mice
Isabelle Landrieu, France: Characterization of Tau interactions using NMR spectroscopy
Eva Maria Mandelkow, Germany: Animal models of Tauopathy
Eckhard Mandelkow, Germany: Structural aspects of Tau
Miguel Medina, Spain: Tau secretion and toxicity
Amrit Mudher, UK: One protein, 6 isoforms, numerous functions: isoform-specific tau-toxicity
Maï Panchal, LECMA, France: Presentation of LECMA-Vaincre Alzheimer and its European network of non-profit organizations
Amy Pooler, Switzerland: Human tau propagation in the absence of mouse tau
Alberto Rabano, Spain: Tau immunoreactive nuclear indentations in the entorhinal cortex of early Alzheimer's pathology
Anne Rovelet-Lecrux, France Tau and MAPT duplication
Melita Salkovic, Croatia: Pathology of tau protein in a non-transgenic rat model of sporadic Alzheimer's disease
Rosa Sancho, ARUK, UK: Funding opportunities
Laura Sayas, Spain: Interplay between tau and End binding proteins in neuronal cells
Wiep Scheper, The Netherlands: UPR and tau pathology
Efthimios Skoulakis, Greece: Tau as a metalloprotein
Ioannis Sotiropoulos, Portugal: role of Tau on stress-related brain pathologies
Maria Grazia Spillantini, UK: Neurons and glia interaction in tauopathies
Selina Wray, UK: Human stem cell derived neurons as models of tauopathy
Norbert Zilka, Tomas Smolek, Michal Novak, Slovakia: The driver and the others: Monitoring of human AD tau spreading in vivo
"Cras elementum ultrices diam."
A service on your city
Alzheimer & Tauopathies - Luc Buée
Copyright 2020